Profil
Jaivir Pall is the founder of Well Technologies Ltd, which was founded in 2018.
He is currently working as an Investment Director at Zubi Capital since 2023 and as an Advisor at BioSapien, Inc. since 2020.
Mr. Pall completed his undergraduate degree from the University of Warwick in 2012.
Aktive Positionen von Jaivir Pall
| Unternehmen | Position | Beginn |
|---|---|---|
Harbr /UK/
 Harbr /UK/ Investment ManagersFinance Well Technologies Ltd (Harbr) is a venture capital firm founded in 2017 by Daniel Omar and Jaivir Pall. The firm is headquartered in Birmingham, United Kingdom. | Gründer | 01.04.2018 |
BioSapien, Inc.
 BioSapien, Inc. Packaged SoftwareTechnology Services BioSapien, Inc. is a company that offers a joint solution to the problems of surgery and chemotherapy. The company is based in New York, NY. The company's technology, medichip™, is a delivery platform designed to deliver drugs directly onto a local site, with an initial indication for treating locally advanced unresectable tumor(s). The company aims to reduce patient burden and decrease patient non-compliance caused by the serious side effect profile of systemic chemotherapy. The company was founded by Khatija Ali, who has been the CEO since incorporation. | Berater | 01.02.2020 |
Zubi Capital
 Zubi Capital Investment ManagersFinance Zubi Venture Capital (Zubi Venture Capital) is a venture capital subsidiary of Zubi Labs SL founded in 2020. The firm is headquartered in Salamanca, Spain. | Private Equity Investor | 01.02.2023 |
Ausbildung von Jaivir Pall
| University of Warwick | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BioSapien, Inc.
BioSapien, Inc. Packaged SoftwareTechnology Services BioSapien, Inc. is a company that offers a joint solution to the problems of surgery and chemotherapy. The company is based in New York, NY. The company's technology, medichip™, is a delivery platform designed to deliver drugs directly onto a local site, with an initial indication for treating locally advanced unresectable tumor(s). The company aims to reduce patient burden and decrease patient non-compliance caused by the serious side effect profile of systemic chemotherapy. The company was founded by Khatija Ali, who has been the CEO since incorporation. | Technology Services |
Zubi Capital
Zubi Capital Investment ManagersFinance Zubi Venture Capital (Zubi Venture Capital) is a venture capital subsidiary of Zubi Labs SL founded in 2020. The firm is headquartered in Salamanca, Spain. | Finance |
Harbr /UK/
Harbr /UK/ Investment ManagersFinance Well Technologies Ltd (Harbr) is a venture capital firm founded in 2017 by Daniel Omar and Jaivir Pall. The firm is headquartered in Birmingham, United Kingdom. | Finance |
